← Leaderboards
Danwei Huangfu
Sloan-Kettering Inst Can Research
$13,557,080
Attributed
$26,878,173
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.3M · FY2012–25$10M$7.5M$5M$2.5M$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$26,878,173 · 6
By mechanism
U01$10,546,019 · 2
R01$9,015,712 · 3
UM1$7,316,442 · 1
Top collaborators
- Anna-Katerina Hadjantonakis11 shared
- Michael A Beer8 shared
- Effie Apostolou5 shared
- Christina S Leslie5 shared
- Todd R Evans4 shared
- Lorenz P. Studer4 shared
- Alexandra L. Joyner3 shared
Most similar at Sloan-Kettering Inst Can Research
Same institution · by research overlap
- Anna-Katerina Hadjantonakis$18,599,624
- Alexandra L. Joyner$25,672,739
- Lorenz P. Studer$24,153,805
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsGeneticGenesEmbryonic DevelopmentResearch PersonnelPublishingAtac-SeqResolutionPhenotypeTranscription FactorEmbryoComplexSignal TransductionCell PhysiologyCell TypeStem Cell DifferentiationDiabetes MellitusMalignant NeoplasmsGene ExpressionHuman Embryonic Stem CellScreeningGenomicsHuman DevelopmentRegulatory Element
Grant awards (34)
Center for scalable knockout and multimodal phenotyping in genetically diverse human genomes$1,781,395
UM1 · FY2025 · HG · contact PI
Genomic control of gene regulatory networks governing early human lineage decisions$1,303,398
U01 · FY2025 · HG · contact PI
Regulation of DNA methylation by TETs and QSER1$671,048
R01 · FY2025 · HD
Center for scalable knockout and multimodal phenotyping in genetically diverse human genomes$1,775,939
UM1 · FY2024 · HG · contact PI
Genomic control of gene regulatory networks governing early human lineage decisions$1,303,398
U01 · FY2024 · HG · contact PI
Discovery of diabetes-relevant ÃÂò cell enhancers through 4D enhancer mapping, integrative analysis, and large-scale CRISPRi perturbation screens$698,106
U01 · FY2024 · DK · contact PI
Regulation of DNA methylation by TETs and QSER1$664,338
R01 · FY2024 · HD
Genomic control of gene regulatory networks governing early human lineage decisions$238,730
U01 · FY2024 · HG · contact PI
Center for scalable knockout and multimodal phenotyping in genetically diverse human genomes$1,816,637
UM1 · FY2023 · HG · contact PI
Genomic control of gene regulatory networks governing early human lineage decisions$1,330,000
U01 · FY2023 · HG · contact PI
Discovery of diabetes-relevant β cell enhancers through 4D enhancer mapping, integrative analysis, and large-scale CRISPRi perturbation screens$698,106
U01 · FY2023 · DK · contact PI
Regulation of DNA methylation by TETs and QSER1$671,048
R01 · FY2023 · HD
Genomic control of gene regulatory networks governing early human lineagedecisions$103,202
U01 · FY2023 · HG · contact PI
Genomic control of gene regulatory networks governing early human lineagedecisions$97,511
U01 · FY2023 · HG · contact PI
Center for scalable knockout and multimodal phenotyping in genetically diverse human genomes$1,942,471
UM1 · FY2022 · HG · contact PI
Genomic control of gene regulatory networks governing early human lineage decisions$1,330,000
U01 · FY2022 · HG · contact PI
Discovery of diabetes-relevant ÃÂò cell enhancers through 4D enhancer mapping, integrative analysis, and large-scale CRISPRi perturbation screens$698,106
U01 · FY2022 · DK · contact PI
Regulation of DNA methylation by TETs and QSER1$688,423
R01 · FY2022 · HD
Genetic Analysis of Morphogenesis in the Mouse Embryo$634,282
R01 · FY2022 · HD
Genomic control of gene regulatory networks governing early human lineage decisions$1,330,000
U01 · FY2021 · HG · contact PI
Discovery of diabetes-relevant ÃÂò cell enhancers through 4D enhancer mapping, integrative analysis, and large-scale CRISPRi perturbation screens$698,106
U01 · FY2021 · DK · contact PI
Genetic Analysis of Morphogenesis in the Mouse Embryo$636,950
R01 · FY2021 · HD
Understanding human pancreas development for diabetes cell-replacement therapy$570,128
R01 · FY2021 · DK · contact PI
Discovery of diabetes-relevant ÃÂò cell enhancers through 4D enhancer mapping, integrative analysis, and large-scale CRISPRi perturbation screens$717,356
U01 · FY2020 · DK · contact PI
Genetic Analysis of Morphogenesis in the Mouse Embryo$655,914
R01 · FY2020 · HD
Understanding human pancreas development for diabetes cell-replacement therapy$570,128
R01 · FY2020 · DK · contact PI
Understanding human pancreas development for diabetes cell-replacement therapy$570,128
R01 · FY2019 · DK · contact PI
Understanding human pancreas development for diabetes cell-replacement therapy$570,128
R01 · FY2018 · DK · contact PI
Understanding Pancreatic Progenitors for Diabetes Cell-Replacement Therapy$397,808
R01 · FY2016 · DK · contact PI
Understanding Pancreatic Progenitors for Diabetes Cell-Replacement Therapy$466,848
R01 · FY2015 · DK · contact PI
Understanding Pancreatic Progenitors for Diabetes Cell-Replacement Therapy$397,808
R01 · FY2014 · DK · contact PI
Understanding Pancreatic Progenitors for Diabetes Cell-Replacement Therapy$69,040
R01 · FY2014 · DK · contact PI
Understanding Pancreatic Progenitors for Diabetes Cell-Replacement Therapy$383,885
R01 · FY2013 · DK · contact PI
Understanding Pancreatic Progenitors for Diabetes Cell-Replacement Therapy$397,808
R01 · FY2012 · DK · contact PI